Trump Administration to Announce Autism-Related Drug Research and Tylenol Risk Advisory

The TRUMP administration is poised to reveal groundbreaking research supporting leucovorin, a decades-old, low-cost drug, as a potential treatment for autism. Early trials have shown promise in improving communication among children with autism. "I think you're going to find it to be amazing," Trump said. "I think we found an answer to autism."

In a separate development, the administration plans to issue a statement linking acetaminophen, the active ingredient in Tylenol, to an increased risk of autism in children when taken during pregnancy. Kenvue (KVUE), Tylenol's manufacturer, saw its stock drop sharply ahead of the announcement. The company disputes the claim, citing independent science that shows no such link. Medical experts, including former FDA Commissioner Scott Gottlieb, have also questioned the validity of the connection.